drugset / Trial / NCT04905901

Nebulized Tranexamic Acid in Sinus Surgery

NCT04905901

Phase 3 Completed 90 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

The results of several recent studies on endoscopic sinus surgery through topical administration of tranexamic acid are encouraging in terms of the efficacy of tranexamic acid for intraoperative bleeding and other pathological conditions.The purpose of this study is to analyze the efficacy of nebulized tranexamic acid to improve the surgeon and patient experiences of sinus surgery and know the effective and safe dose of nebulized tranexamic acid.

Timeline

Start
2021-05-06
Primary completion
2026-06-05
Completion
2026-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 500 mg Other
Subject Tranexamic Acid Small molecule 1 g Other